ReviewWorld journal of gastroenterology2018

Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence.

Maria Lia ScribanoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.